Antifungal interaction study launched for ovarian cancer drug
NCT ID NCT07402915
First seen Feb 15, 2026 · Last updated May 22, 2026 · Updated 16 times
Summary
This study looks at how the antifungal drug itraconazole changes the way the body processes a cancer drug called AZ14170132, which is part of a targeted therapy for ovarian, peritoneal, and fallopian tube cancers. About 24 people with these cancers will take both drugs in a fixed order, and researchers will measure drug levels in the blood. The goal is to understand potential drug interactions, not to treat the cancer directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
NOT_YET_RECRUITINGBatumi, 6010, Georgia
-
Research Site
NOT_YET_RECRUITINGTbilisi, 0114, Georgia
-
Research Site
NOT_YET_RECRUITINGTbilisi, 112, Georgia
-
Research Site
RECRUITINGDublin, D07 R2WY, Ireland
-
Research Site
RECRUITINGLisbon, 1250-068, Portugal
-
Research Site
RECRUITINGBarcelona, 08023, Spain
-
Research Site
RECRUITINGLogroño, 26006, Spain
-
Research Site
RECRUITINGMadrid, 28040, Spain
-
Research Site
RECRUITINGMadrid, 28050, Spain
Conditions
Explore the condition pages connected to this study.